Kaiso represses the expression of glucocorticoid receptor via a methylation-dependent mechanism and attenuates the anti-apoptotic activity of glucocorticoids in breast cancer cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Kaiso is a Pox Virus and Zinc Finger (POZ-ZF) transcription factor with bi-modal DNA-binding specificity. Here, we demonstrated that Kaiso expression is inversely correlated with glucocorticoid receptor (GR) expression in breast carcinomas. Knockdown of Kaiso increased GR expression, while overexpression of Kaiso inhibited GR expression in breast cancer cells. Furthermore, Kaiso repressed GR proximal promoter-reporter activity in a dose-dependent manner. Remarkably, ChIP experiments demonstrated that endogenous Kaiso was associated with the GR promoter sequence in a methylation-dependent manner. Since glucocorticoids inhibit chemotherapyinduced apoptosis and have been widely used as a co-treatment of patients with breast cancer, we assessed the role of Kasio in GR-mediated anti-apoptotic effects. We found that overexpression of Kaiso attenuated the anti-apoptotic effects of glucocorticoids in breast cancer cells. Our findings suggest that GR is a putative target gene of Kaiso and suggest Kaiso to be a potential therapeutic target in GC-combination chemotherapy in breast cancer.
Abstract
Kaiso is a Pox Virus and Zinc Finger (POZ-ZF) transcription factor with bi-modal DNA-binding specificity. Here, we demonstrated that Kaiso expression is inversely correlated with glucocorticoid receptor (GR) expression in breast carcinomas. Knockdown of Kaiso increased GR expression, while overexpression of Kaiso inhibited GR expression in breast cancer cells. Furthermore, Kaiso repressed GR proximal promoter-reporter activity in a dose-dependent manner. Remarkably, ChIP experiments demonstrated that endogenous Kaiso was associated with the GR promoter sequence in a methylation-dependent manner. Since glucocorticoids inhibit chemotherapyinduced apoptosis and have been widely used as a co-treatment of patients with breast cancer, we assessed the role of Kasio in GR-mediated anti-apoptotic effects. We found that overexpression of Kaiso attenuated the anti-apoptotic effects of glucocorticoids in breast cancer cells. Our findings suggest that GR is a putative target gene of Kaiso and suggest Kaiso to be a potential therapeutic target in GC-combination chemotherapy in breast cancer.
참고문헌 (23)
- Daniel JM, "The catenin p120(ctn)interacts with Kaiso, a novel BTB", POZ domain zinc finger transcription factor, 1999, pp.19, 3614~3623
- Daniel JM, "The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus, methylated CpG dinucleotides", Nucleic Acids Res, 30, pp.2911~2919 (2002)
- Ruzov A, "Kaiso is a genome-wide repressor of transcription that is essential for amphibian development", Development, 131, pp.6185~6194 (2004)
- Donaldson NS, "Kaiso regulates Znf131-mediated transcriptional activation", Exp Cell Res, 316, pp.1692~1705 (2010)
- Rodova M, "Regulation of the rapsyn promoter by kaiso, delta-catenin", Mol Cell Biol, 24, pp.7188~7196 (2004)
- Vermeulen JF, "Nuclear Kaiso expression is associated with high grade, triple-negative invasive breast cancer", PLoS One, 7, pp.e37864~ (2012)
- Jones J, "Nuclear localization of Kaiso promotes the poorly differentiated phenotype, EMT in infiltrating ductal carcinomas", Clin Exp Metastasis, 31, pp.497~510 (2014)
- Conzen SD, "Minireview : nuclear receptors, breast cancer", Mol Endocrinol, 22, pp.2215~2228 (2008)
- Karmakar S, "Interaction of glucocorticoid receptor(GR)with estrogen receptor(ER)alpha, activator protein 1(AP1)in dexamethasonemediated interference of ERalpha activity", J Biol Chem, 288, pp.24020~24034 (2013)
- Ling J, "Crosstalk between NFkB, glucocorticoid signaling: a potential target of breast cancer therapy", Cancer Lett, 322, pp.119~126 (2012)
- Vilasco M, "Glucocorticoid receptor, breast cancer", Breast Cancer Res Treat, 130, pp.1~10 (2011)
- Nesset KA, "Frequent promoter hypermethylation, expression reduction of the glucocorticoid receptor gene in breast tumors", Epigenetics, 9, pp.851~859 (2014)
- Yemelyanov A, "Tumor suppressor activity of glucocorticoid receptor in the prostate", Oncogene, 26, pp.1885~1896 (2007)
- Chebotaev D, "The tumor suppressor effect of the glucocorticoid receptor in skin is mediated via its effect on follicular epithelial stem cells", Oncogene, 26, pp.3060~3068 (2007)
- Kay P, "Loss of glucocorticoid receptor expression by DNA methylation prevents glucocorticoid induced apoptosis in human small cell lung cancer cells", PLoS One, 6, pp.e24839~ (2011)
- Lind GE, "ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis", Cell Oncol, 28, pp.259~272 (2006)
- Mikosz CA, "Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine", threonine survival kinase gene, sgk-1, 2001, pp.276, 16649~16654
- Machuca C, "Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB, is independent from AKT", BMC Cell Biol, 7, pp.9~ (2006)
- Schorr K, "Induction of bcl-xL expression in mammary epithelial cells is glucocorticoid-dependent but not signal transducer, activator of transcription 5-dependent", Cancer Res, 60, pp.5950~5953 (2000)
- Wu W, "Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells", Cancer Res, 64, pp.1757~1764 (2004)
- Lopes EC, "Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines", Cancer Res, 68, pp.7258~7263 (2008)
- Turner JD, "Transcriptional control of the glucocorticoid receptor: CpG islands, epigenetics, more", Biochem Pharmacol, 80, pp.1860~1868 (2010)
- Yoon HG, "N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso", Mol Cell, 12, pp.723~734 (2003)